drugset / Trial / NCT06006143
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 2
Phase 2
Active not recruiting
30 enrolled
Yale University
National Institute on Alcohol Abuse and Alcoholism (NIAAA) · collab
NaSingle-groupOpen-labelTreatment
Summary
This study seeks to determine the feasibility, acceptability, and preliminary efficacy of an intervention consisting of off-label use of a medication with strong efficacy data for alcohol use disorder (AUD) with medical management and a clinical pharmacist-delivered behavioral intervention in reducing alcohol use among individuals with HIV and AUD.
Timeline
- Start
- 2025-06-16
- Primary completion
- 2026-08-31
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Varenicline | Small molecule | — | — |